william makis md, dr william makis, turbo cancer, cancer, mRNA vaccines, covid jabs, adverse events, oncology

William Makis MD - Is Turbo Cancer Big Pharma's New Cash Cow?

5 K Views - Published on 18 Jan, 2024
⁣Dr William Makis is the author of over 100 publications and many are on Cancer. We have seen the terms 'aggressive cancer' and 'turbo cancer' appear much more frequently and many press articles have been written asking why we are seeing so many cases of cancer in young people than we seemingly did before Covid. Dr Makis joins us to discuss this new trend in oncology and how it fits into a possible side effect of the mRNA jab. He explains what is different about these cancers and how Big Pharma is profiting from it. These so called 'vaccines' are no longer a gold mine for this industry which could be why we are seeing multibillion dollar deals for cancer drug companies as pharma looks for the next big thing. Dr William Makis is a Canadian doctor with expertise in Radiology, Oncology and Immunology and a unique perspective on COVID-19, Vaccines and medical ethics. He obtained a 4 year undergraduate degree in Immunology at University of Toronto, medical degree at McGill University and a 5 year medical specialization in Nuclear Medicine Radiology and Oncology. Dr Makis worked for AHS at Cross Cancer Institute as the Head of the Medical Isotope Cancer Treatment Program, and as an Assistant Professor in the Department of Radiology at the University of Alberta. He is the author of over 100 peer-reviewed publications in international medical journals. Connect with Dr Makis... X https://x.com/MakisMD?s=20 GETTR https://gettr.com/user/makismd SUBSTACK http://makismd.substack.com/ Interview recorded 15.1.24 Connect with Hearts of Oak... WEBSITE https://heartsofoak.org/ PODCASTS https://heartsofoak.podbean.com/ SOCIAL MEDIA https://heartsofoak.org/connect/ Support Hearts of Oak by purchasing one of our fancy T-Shirts.... SHOP https://heartsofoak.org/shop/
Hearts of Oak

Hearts of Oak

54 K
Authentication required

You must log in to post a comment.

Log in